Literature DB >> 18022711

Inflammatory markers in stable heart failure and their relationship with functional class.

Ignacio J Sánchez-Lázaro1, Luis Almenar, Edelmiro Reganon, Virtudes Vila, Luis Martínez-Dolz, Vicenta Martínez-Sales, José Moro, Jaime Agüero, Víctor Ortiz-Martínez, Antonio Salvador.   

Abstract

INTRODUCTION AND
OBJECTIVES: While it appears to be clear that an inflammatory process occurs in heart failure (HF), it is still to be defined whether inflammation depends to a greater extent on HF etiology, functional class (FC), or the extent of depression of ejection fraction (EF). Our objectives were to analyze differences in inflammatory marker levels as compared to a healthy population, to assess differences depending on HF etiology, and to relate values with FC and EF. PATIENTS AND METHODS: Fifty-nine consecutive outpatients with stable HF (57 + or - 9 years, 89% males) and 59 controls (55 + or - 8 years, 85% males) were enrolled into the study. Causes of HF included ischemic heart disease (n=24), idiopathic dilated cardiomyopathy (n=24), and miscellaneous conditions (n=11). Patients with decompensation in the past 6 months were excluded from the study. Protein fibrinogen, sialic acid, C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-alpha) were measured. Echocardiography was performed in all study patients. FC was assessed using the NYHA classification.
RESULTS: A comparison of inflammatory marker levels between the HF and control groups showed significant differences in all markers, except for TNF-alpha. Protein fibrinogen in controls: 253 + or - 54 mg/dl, protein fibrinogen in HF: 294 + or - 67 mg/dl; p<0.05. Sialic acid in controls: 53 + or - 1 mg/dl, sialic acid in HF: 61 + or - 12 mg/dl; p<0.05. CRP in controls: 1.3 + or - 0.7 mg/dl, CRP in HF: 7.8 + or - 1.2 mg/dl; p<0.05. TNF-alpha in controls: 183 + or - 51 ng/ml, TNF-alpha in HF: 203 + or - 13 ng/ml; p=0.2. No differences were found between the different etiologies of HF. A positive association was seen between FC and protein fibrinogen and TNF-alpha (p<0.05), but not with EF.
CONCLUSIONS: Increased inflammatory marker levels related to FC of the patient, but not to EF, are found in chronic HF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18022711     DOI: 10.1016/j.ijcard.2007.07.138

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Determinants of exercise capacity in dilated cardiomyopathy: a prospective, explorative cohort study.

Authors:  Wilhelm Grander; Bernhard Koller; Johannes Schwaiger; Herbert Tilg; Martin W Dünser
Journal:  Wien Klin Wochenschr       Date:  2012-08-10       Impact factor: 1.704

2.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

Review 3.  Biologics and heart failure in rheumatoid arthritis: are we any wiser?

Authors:  Maria I Danila; Nivedita M Patkar; Jeffrey R Curtis; Kenneth G Saag; Gim Gee Teng
Journal:  Curr Opin Rheumatol       Date:  2008-05       Impact factor: 5.006

4.  Systemic inflammation in nonischemic dilated cardiomyopathy.

Authors:  Luisa De Gennaro; Natale Daniele Brunetti; Andrea Cuculo; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

5.  Are there differences in acute phase inflammation markers regarding the type of heart failure?

Authors:  Ignacio J Sánchez-Lázaro; Luis Almenar-Bonet; Edelmiro Reganon-Salvador; Virtudes Vila-Liante; Vicenta Martínez-Sales; Luis Martínez-Dolz; Jaime Agüero-Ramón-Llin; Antonio Salvador-Sanz
Journal:  Heart Int       Date:  2011-10-21

6.  Predictive value of elevated neutrophil-lymphocyte ratio for left ventricular systolic dysfunction in patients with non ST-elevated acute coronary syndrome.

Authors:  Adem Bekler; Gokhan Erbag; Hacer Sen; Emine Gazi; Sedat Ozcan
Journal:  Pak J Med Sci       Date:  2015 Jan-Feb       Impact factor: 1.088

7.  Could elevated platelet-lymphocyte ratio predict left ventricular systolic dysfunction in patients with non-ST elevated acute coronary syndrome?

Authors:  Adem Bekler; Emine Gazi; Mustafa Yılmaz; Ahmet Temiz; Burak Altun; Ahmet Barutçu; Tezcan Peker
Journal:  Anatol J Cardiol       Date:  2014-04-16       Impact factor: 1.596

8.  C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up.

Authors:  Maarten Vanhaverbeke; Denise Veltman; Nele Pattyn; Nico De Crem; Hilde Gillijns; Véronique Cornelissen; Stefan Janssens; Peter R Sinnaeve
Journal:  Clin Cardiol       Date:  2018-09-20       Impact factor: 2.882

Review 9.  Neurohormones, inflammatory mediators, and cardiovascular injury in the setting of heart failure.

Authors:  Liza Grosman-Rimon; Filio Billia; Evan Wright; Shemy Carasso; Gabby Elbaz-Greener; Erez Kachel; Vivek Rao; David Cherney
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.